What Keeps Dr. Eric Goosby Up at Night?
You’ll find the answer to that question, and other fresh insights into the Administration’s plans for PEPFAR, in this ScienceInsider interview with Dr. Goosby, President Obama’s global AIDS...
View ArticleHIV/AIDS Physician-Scientists, Advocates Call for Bold HIV Treatment Goals...
Physician-scientists working on the frontlines of the HIV/AIDS epidemic today urged the White House to set bold new HIV treatment targets for PEPFAR, the U.S. President’s Emergency Plan for AIDS...
View ArticleGroups to Global Fund, PEPFAR: Support switch from toxic treatment
Imagine a country that, while poor, serves as something of a model for getting treatment for HIV out to those who need it – addressing obstacles that can make the vision of full-scale coverage and...
View ArticleWith study of injecting drug users, preventive HIV medicine demonstrates...
CDC releases updated Guidance for Pre-Exposure Prophylaxis for the Prevention of HIV Infection: PrEP for Injecting Drug Users, while questions on real-world impact remain With a five-year study in...
View ArticlePrEP: Risk of resistance to antiretroviral drugs used to prevent infection is...
Categories: Research and DevelopmentTags: emtricitabine, Journal of Infectious Diseases, PReP, tenofovirHighest risk of resistance found in those starting drugs with undiagnosed infection, pointing to...
View Article
